245 related articles for article (PubMed ID: 4015734)
1. Pharmacological studies of a newly synthetized 1,4-dihydropyridine derivative, 2,6-dimethyl-3,5-dimethoxycarbonyl-4- (o-difluoromethoxyphenyl)-1,4-dihydropyridine (PP-1466).
Toribatake T; Fujii K; Kobayashi M; Okumura M; Aikawa K
Arzneimittelforschung; 1985; 35(4):680-6. PubMed ID: 4015734
[TBL] [Abstract][Full Text] [Related]
2. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
[TBL] [Abstract][Full Text] [Related]
3. Regional vasodilating and cardiac effects of nicardipine in anaesthetized open chest dog.
Bongrani S; Razzetti R; Schiantarelli P
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):226-36. PubMed ID: 4004418
[TBL] [Abstract][Full Text] [Related]
4. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
[TBL] [Abstract][Full Text] [Related]
5. Effect of vasoactive intestinal polypeptide on the canine cardiovascular system.
Unverferth DV; O'Dorisio TM; Muir WW; White J; Miller MM; Hamlin RL; Magorien RD
J Lab Clin Med; 1985 Nov; 106(5):542-50. PubMed ID: 4056568
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and toxicological properties of ryodipine.
Kimenis AA; Vitolina RO; Petersone IO; Germane SK; Briede JL
Arzneimittelforschung; 1985; 35(4):672-9. PubMed ID: 4015733
[TBL] [Abstract][Full Text] [Related]
7. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
Kopia GA; Ohlstein EH; Ruffolo RR
J Pharmacol Exp Ther; 1988 Aug; 246(2):434-40. PubMed ID: 3404441
[TBL] [Abstract][Full Text] [Related]
8. Effects of niguldipine, a new dihydropyridine calcium antagonist, on regional blood flow, cardiac performance and myocardial metabolism in anaesthetized open-chest dogs.
Fischer G; Schneider W; Krumpl G; Grohs JG; Raberger G
Arch Int Pharmacodyn Ther; 1989; 298():96-107. PubMed ID: 2757470
[TBL] [Abstract][Full Text] [Related]
9. Investigation on the effect of dipyridamole and papaverine on regional blood flow and cardiac hemodynamics in anesthetized dogs.
Sakanashi M; Noguchi K; Kato T; Matsuzaki T; Kinjo N; Ikema S; Miyagi H; Moromizato H; Nakasone J; Kinjo Y
Arzneimittelforschung; 1989 Sep; 39(9):1119-23. PubMed ID: 2590262
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia.
Jolly SR; Hardman HF; Gross GJ
J Pharmacol Exp Ther; 1981 Apr; 217(1):20-5. PubMed ID: 7205654
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of the new calcium antagonist benidipine hydrochloride on myocardial dysfunction following coronary occlusion and reperfusion in anesthetized dogs.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1717-21. PubMed ID: 3219147
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs.
Sakanashi M; Noguchi K; Miyamoto Y; Kato T; Nagamine F; Yu WY; Higuchi M; Nakasone J
Arch Int Pharmacodyn Ther; 1988; 294():159-74. PubMed ID: 2976588
[TBL] [Abstract][Full Text] [Related]
14. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
15. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.
Kawashima S; Liang CS
J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638
[TBL] [Abstract][Full Text] [Related]
16. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
Satoh K; Kawada M; Wada Y; Taira N
Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
[TBL] [Abstract][Full Text] [Related]
18. [The effect of Hongjingtian (Gadol) injection on cardiac hemodynamics and myocardial oxygen consumption of dogs].
Zhang ZH; Liu JS; Chu JN; Shang XH; Lin CR; Ma XB; Shi TR; Wang M; Wang YH; Li YR; Liu JH; Wu XY; Zhang XD; Zhang DS; Zhao ZH
Zhongguo Zhong Yao Za Zhi; 2005 Jul; 30(13):1001-5. PubMed ID: 16161429
[TBL] [Abstract][Full Text] [Related]
19. Characteristic cardiovascular effects of RA642, a pyrimido-pyrimidine derivative, in anesthetized dogs.
Koyama S
J Pharmacol Exp Ther; 1985 May; 233(2):480-4. PubMed ID: 3999030
[TBL] [Abstract][Full Text] [Related]
20. [Effects of glucagon on systemic circulation, coronary blood flow and myocardial oxygen consumption in the anesthetized dog (author's transl)].
Tarnow J; Gethmann JW; Patschke D; Weymar A; Eberlein HJ
Arzneimittelforschung; 1975; 25(12):1906-10. PubMed ID: 1243661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
